参考文献/References:
[1]Pontremoli R,Borghi C,Perrone Filardi P.Renal protection in chronic heart failure: focus on sacubitril/valsartan[J].Eur Heart J Cardiovasc Pharmacother,2021,7(5):445-452.[2]McDonagh TA,Metra M,Adamo M,et al.2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure[J].Eur Heart J,2021,42(36):3599-3726.[3]Ben Gal T,Ben Avraham B,Milicic D,et al.Guidance on the management of left ventricular assist device(LVAD) supported patients for the non-LVAD specialist healthcare provider: executive summary[J].Eur J Heart Fail,2021,23(10):1597-1609.[4]Chera HH,Al-Sadawi M,Michelakis N,et al.Optimizer Smart System for the treatment of chronic heart failure: Overview of its safety and efficacy[J].Expert Rev Med Devices,2021,18(6):505-512.[5]Mogensen UM,K?覬ber L,S?覬ren L,et al.The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF[J].American Heart Journal,2017,188:35-41.[6]Balmforth C,Simpson J,Shen L,et al.Outcomes and Effect of Treatment According to Etiology in HFrEF: An Analysis of PARADIGM-HF[J].J Am Coll Cardiol Heart Fail,2019,7(6)457-465.[7]Vaduganathan M,Claggett B,Jhund P,et al.Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials[J].Lancet,2020,396(10244):121-128.[8]McMurray JJ,Packer M.How Should We Sequence the Treatments for Heart Failure and a Reduced Ejection Fraction? A Redefinition of Evidence-Based Medicine[J].Circulation.2021,143:875-877.[9]Yeoh SE,Dewan P,Serenelli M,et al.Effects of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction patients with chronic obstructive pulmonary disease in EMPHASIS-HF and RALES[J].Eur J Heart Fail,2022,24(3):529-538.[10]Catchpool M,Ramchand J,Hare DL,et al.Mapping the Minnesota Living with Heart Failure Questionnaire (MLHFQ) onto the Assessment of Quality of Life 8D (AQoL-8D) utility scores[J].Qual Life Res,2020,29(10):2815-2822.[11]Kusuma DY,Shatri H,Alwi I,et al.Validity and Reliability Studies of the Indonesian Version of the MinnesotaLiving with Heart Failure Questionnaire (MLHFQ):Quality of Life Questionnaire for Patients with Chronic Heart Failure[J].Acta Med Indones,2019,51(1):26-33.[12]Mapelli M,Salvioni E,Paneroni M,et al.Brisk walking can be a maximal effort in heart failure patients: a comparison of cardiopulmonary exercise and 6 min walking test cardiorespiratory data[J].ESC Heart Fail,2022,9(2):812-821.[13]Lancaster L,Fieuw A,Meulemans J,et al.Standardization of the 6-min walk test in clinical trials of idiopathic pulmonary fibrosis[J].Contemp Clin Trials,2021,100:106227.[14]Kinoshita H,Sairaku A,Morishima N,et al.Prognostic significance of oscillatory ventilation at rest in patients with advanced heart failure undergoing cardiopulmonary exercise testing[J].Int J Cardiol,2020,301:142-146.[15]Pryor JL,Leija RG,Morales J,Potter AW,et al.Verification Testing to Confirm VO2max in a Hot Environment[J].Med Sci Sports Exerc,2021,53(4):763-769.[16]Wang R,Zhang Z,Xu Z,et al.Gastrin mediates cardioprotection through angiogenesis after myocardial infarction by activating the HIF-1α/VEGF signalling pathway[J].Sci Rep,2021,11(1):15836.[17]Chen F,Tian G,Bai X,et al.The effect of Sacubitril/Valsartan on cardiac function and cardiac remodeling in patients with heart failure with reduced ejection fraction[J].Ann Palliat Med,2021,10(8):8684-8691.[18]Fu J,Tang Y,Zhang Z,et al.Gastrin exerts a protective effect against myocardial infarction via promoting angiogenesis[J].Mol Med,2021,27(1):90.[19]Bao J,Kan R,Chen J,et al.Combination pharmacotherapies for cardiac reverse remodeling in heart failure patients with reduced ejection fraction:A systematic review and network meta-analysis of randomized clinical trials[J].Pharmacol Res,2021,169:105573.[20]Mc Donagh TA,Metra M,Adamo M,et al.2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure[J].Eur Heart J,2021,42(36):3599-3726.[21]Heidenreich PA,Bozkurt B,Aguilar D,et al.2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J].Circulation,2022,145(18):e895-e1032.[22]Ahn MS,Yoo BS,Son JW,et al.Evaluation of Adherence to Guideline for Heart Failure with Reduced Ejection Fraction in Heart Failure with Preserved Ejection Fraction and with or without Atrial Fibrillation[J].J Korean Med Sci,2021,36(40):e252.[23]Ferreira JP,Anker SD,Butler J,et al.Impact of anaemia and the effect of empagliflozin in?heart failure with reducedejection fraction: findings from EMPEROR-Reduced[J].Eur J Heart Fail,2022,24(4):708-715.[24]Carnicelli AP,Li Z,Greiner MA,et al.Sacubitril/Valsartan Adherence and Postdischarge Outcomes Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction[J].JACC Heart Fail,2021,9(12):876-886.[25]Shen L,Jhund PS,Docherty KF,et al.Accelerated and personalized therapy for heart failure with reduced ejection fraction[J].Eur Heart J,2022,43(27):2573-2587.
相似文献/References:
[1]袁 曦.罗库溴铵与七氟烷用于气管插管的麻醉效果对比分析[J].医学信息,2018,31(12):136.[doi:10.3969/j.issn.1006-1959.2018.12.042]
YUAN Xi.Comparative Analysis of Anesthetic Effects of Rocuronium and Sevoflurane in Tracheal Intubation[J].Journal of Medical Information,2018,31(18):136.[doi:10.3969/j.issn.1006-1959.2018.12.042]
[2]刘 亮,韩建阁.右美托咪定在心血管手术麻醉中的应用[J].医学信息,2022,35(11):60.[doi:10.3969/j.issn.1006-1959.2022.11.017]
LIU Liang,HAN Jian-ge.Application of Dexmedetomidine in Anesthesia of Cardiovascular Surgery[J].Journal of Medical Information,2022,35(18):60.[doi:10.3969/j.issn.1006-1959.2022.11.017]
[3]李树贤,李 倩.宫腔镜手术麻醉中应用右美托咪定与瑞芬太尼复合依托咪酯的效果比较[J].医学信息,2022,35(11):114.[doi:10.3969/j.issn.1006-1959.2022.11.029]
LI Shu-xian,LI Qian.Comparison of the Effect of Dexmedetomidine and Remifentanil Combined with Etomidate in Hysteroscopic Surgery Anesthesia[J].Journal of Medical Information,2022,35(18):114.[doi:10.3969/j.issn.1006-1959.2022.11.029]
[4]马兴对,吴 靓,姬宁宁,等.喉罩替换气管导管在开颅手术苏醒期中的应用研究[J].医学信息,2018,31(23):91.[doi:10.3969/j.issn.1006-1959.2018.23.025]
MA Xing-dui,WU Liang,JI Ning-ning,et al.Observation on the Effect of Laryngeal Mask Replacement Tracheal Tube in the Period of Extubation in Craniotomy[J].Journal of Medical Information,2018,31(18):91.[doi:10.3969/j.issn.1006-1959.2018.23.025]
[5]马孝天,余书康,李贯清.H型高血压与腔隙性脑梗死患者血流动力学变化的相关研究[J].医学信息,2018,31(24):78.[doi:10.3969/j.issn.1006-1959.2018.24.020]
MA Xiao-tian,YU Shu-kang,LI Guan-qing.Correlation between Hemodynamic Changes in Patients with H-type Hypertension and Lacunar Infarction[J].Journal of Medical Information,2018,31(18):78.[doi:10.3969/j.issn.1006-1959.2018.24.020]
[6]王国粉,王繁静,马 滨,等.右美托咪定对脓毒症休克患者围术期血流动力学、乳酸清除率的影响[J].医学信息,2022,35(12):153.[doi:10.3969/j.issn.1006-1959.2022.12.037]
WANG Guo-fen,WANG Fan-jing,MA Bin,et al.Effect of Dexmedetomidine on Perioperative Hemodynamics and Lactate Clearance Rate in Patients with Septic Shock[J].Journal of Medical Information,2022,35(18):153.[doi:10.3969/j.issn.1006-1959.2022.12.037]
[7]赵 悦,董 婕,韩晨阳,等.Bioz.com用于心脏手术围术期监测的临床价值研究[J].医学信息,2019,32(05):108.[doi:10.3969/j.issn.1006-1959.2019.05.033]
ZHAO Yue,DONG Jie,HAN Chen-yang,et al.Clinical Value Study of Bioz.com for Perioperative Monitoring of Cardiac Surgery[J].Journal of Medical Information,2019,32(18):108.[doi:10.3969/j.issn.1006-1959.2019.05.033]
[8]刘世强,邓津津,王 卫.心脏超声对急性心肌梗死心脏功能指标评价的研究[J].医学信息,2022,35(14):180.[doi:10.3969/j.issn.1006-1959.2022.14.047]
LIU Shi-qiang,DENG Jin-jin,WANG Wei.Evaluation of Cardiac Function Indexes of Acute Myocardial Infarction by Echocardiogram[J].Journal of Medical Information,2022,35(18):180.[doi:10.3969/j.issn.1006-1959.2022.14.047]
[9]芦树军,刘云霞,喻文立,等.先天性胆道闭锁合并卵圆孔未闭患儿肝移植围术期血流动力学及心功能变化[J].医学信息,2019,32(20):95.[doi:10.3969/j.issn.1006-1959.2019.20.026]
LU Shu-jun,LIU Yun-xia,YU Wen-li,et al.Changes of Hemodynamics and Cardiac Function During Liver Transplantation Period in Children with Congenital Biliary Atresia with Patent Foramen Ovale[J].Journal of Medical Information,2019,32(18):95.[doi:10.3969/j.issn.1006-1959.2019.20.026]
[10]刘忠涛.罗哌卡因复合亚甲蓝椎旁阻滞对胸腔镜肺段切除术患者血流动力学及术后镇痛的影响[J].医学信息,2022,35(18):44.[doi:10.3969/j.issn.1006-1959.2022.18.010]
LIU Zhong-tao.Effects of Ropivacaine Combined with Methylene Blue Paravertebral Block on Hemodynamics and Postoperative Analgesia in Patients Undergoing Thoracoscopic Segmentectomy[J].Journal of Medical Information,2022,35(18):44.[doi:10.3969/j.issn.1006-1959.2022.18.010]